ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2015

High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib.

Ondrej Fiala et al.PubMed ↗Publisher ↗

No numbers read from the abstract.